This website uses cookies to enhance the user experience.
||
B

BRATBAK CONSULTING AS922 601 054

Limited company
Østtunvegen 4 7023 TRONDHEIM, Norge

BRATBAK CONSULTING AS

Operating
Salg av tjenester innenfor utvikling av medisinsk teknologi. Herunder arbeide med rådgivning, produktutvikling og markedsforståelse, samt forskingsrelaterte oppgaver som design og gjennomføre forskningsprosjekter. Foredragsvirksomhet for ulike firma, fortrinnsvis legemiddelfirma. I tillegg skal selskapet drive med det som står i naturlig forbindelse med dette, herunder deltagelse i andre selskaper med samme eller beslektet formål.
Salg av tjenester innenfor utvikling av medisinsk teknologi. Herunder arbeide med rådgivning, produktutvikling og markedsforståelse, samt forskingsrelaterte oppgaver som design og gjennomføring av forskningsprosjekter. Foredragsvirksomhet for ulike firma, fortrinnsvis legemiddelfirma. I tillegg skal selskapet drive med det som står i naturlig forbindelse med dette, herunder deltagelse i andre selskaper med samme eller beslektet formål.

Organization

Chairman of the board
Years since formation
7 years
since Apr 8, 2019
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
3,000
1 share class
Total number of shareholders
2
persons
Belongs to group of

Financials

Total operating income 2025
306,600
NOK
Annual total result 2025
-216,967
NOK
Total equity 2025
4,204,675
NOK
Last update: Apr 4, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
50 %
directly

Board

NameRoleShares
Chairman
50 %
directly

Others

NameRoleShares
M
MILI ØKONOMI AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
50 %
directly
Managing Director/CEO, Chairman
50 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1,500
50 %
Ordinary shares
1,500
50 %

Shares owned by the BRATBAK CONSULTING AS

NameShare classTotal number of sharesShare
K
KEIMON MEDICAL AS
Ordinary shares
7,200
72 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 306,600
    Operating profit 2025: NOK -278,641
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
306,600
628,800
145,800
1,161,549
704,714
Annual Total Result
-216,967
88,869
92,938
4,209,703
205,050
Total assets
4,553,473
4,682,769
4,612,113
4,529,293
469,095
Total liabilities
348,798
261,127
279,341
289,459
278,964
Total equity
4,204,675
4,421,642
4,332,772
4,239,834
190,131

P&L

Year20252024202320222021
Total operating income
306,600
628,800
145,800
1,161,549
704,714
Total operating costs
585,241
522,361
29,897
844,049
441,831
Operating result
-278,641
106,439
115,903
317,500
262,883
Financial income/costs
471
7,238
3,329
3,961,364
0
Profit before tax
-278,170
113,676
119,232
4,278,865
262,883
Total tax & extraordinary income/cost
-61,203
24,807
26,294
69,162
57,833
Annual Total Result
-216,967
88,869
92,938
4,209,703
205,050

Balance overview

Year20252024202320222021
Total fixed assets
4,186,819
4,125,616
4,125,616
4,027,600
33,000
Total current assets
366,653
557,153
486,497
501,693
436,095
Total assets
4,553,473
4,682,769
4,612,113
4,529,293
469,095
Short term debt
348,798
261,127
279,341
289,459
278,964
Long term debt
0
0
0
0
0
Total liabilities
348,798
261,127
279,341
289,459
278,964
Contributed capital
20,665
20,665
20,665
20,665
20,665
Retained earnings
4,184,010
4,400,977
4,312,107
4,219,169
169,466
Total equity
4,204,675
4,421,642
4,332,772
4,239,834
190,131
Total equity and liabilities
4,553,473
4,682,769
4,612,113
4,529,293
469,095

Classification

21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises